Condition
Prognostic
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06299215Completed
Factors and Prognosis of Obstructive Pyelonephritis Patients
NCT04354558Unknown
French Single Centre Experience of Critically Ill Patients With Covid 19
NCT05501613Completed
Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
NCT01249859Completed
Prognosis of Signet Ring Cells in Upper Digestive Neoplasms
Showing all 4 trials